首页> 美国卫生研究院文献>SpringerPlus >Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa isolated from patients of lower respiratory tract infections
【2h】

Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa isolated from patients of lower respiratory tract infections

机译:从下呼吸道感染患者中分离出的铜绿假单胞菌临床分离株的抗菌药敏模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The present study was conducted to determine the antibiotic susceptibility pattern of Pseudomonas aeruginosa from sputum samples of lower respiratory tract infection patients admitted to different hospitals of Karachi. Most of the hospitals are hampered with high frequency of nosocomial infections generally caused by multiresistant nosocomial pathogen. Among Gram-negative pathogens Pseudomonas aeruginosa considered as most challenging pathogen. The objective of the study was to determine frequency of Pseudomonas aeruginosa from sputum samples and to find out susceptibility pattern against four antibiotics widely used for treatment. The sputum samples from 498 patients were collected consecutively between January 2010 and March 2011 and were cultured and identified. According to CLSI (Clinical Laboratory Standards Institute) guidelines antimicrobial susceptibility testing was performed by disc diffusion method. Pseudomonas aeruginosa were isolated from 24% (120/498) of the lower respiratory tract patient. A higher resistance to Pseudomonas aeruginosa isolate was observed with piperacillin/tazobactam and cefipime i.e. 42% and 40% respectively. Imipenem was found to be most effective antibiotic against Pseudomonas aeruginosa (76% sensitivity) but amikacin resistance was continuously increasing. In conclusion the frequency of Pseudomonas aeruginosa was also higher among lower respiratory tract infection patients with alarmingly high rate of resistance among widely used antibiotics. These findings focused on careful consideration for monitoring and optimization of antimicrobial use in order to reduce occurrence and spread of antimicrobial resistant pathogen.
机译:本研究旨在确定卡拉奇不同医院的下呼吸道感染患者痰液样本中铜绿假单胞菌的抗生素敏感性模式。大多数医院都受到通常由多重耐药性医院病原体引起的医院感染的频繁发生的困扰。在革兰氏阴性病原体中,铜绿假单胞菌被认为是最具挑战性的病原体。该研究的目的是确定痰液样本中铜绿假单胞菌的频率,并找出对四种广泛用于治疗的抗生素的敏感性模式。从2010年1月至2011年3月连续收集了498例患者的痰标本,并进行了培养和鉴定。根据CLSI(临床实验室标准协会)指南,通过椎间盘扩散法进行了药敏试验。从24%(120/498)的下呼吸道患者中分离出铜绿假单胞菌。哌拉西林/他唑巴坦和头孢吡肟对铜绿假单胞菌分离株的耐药性较高,分别为42%和40%。亚胺培南被发现是最有效的铜绿假单胞菌抗生素(敏感性为76%),但对丁胺卡那霉素的耐药性正在不断增加。总之,在下呼吸道感染患者中,铜绿假单胞菌的频率也较高,在广泛使用的抗生素中耐药率高得惊人。这些发现侧重于仔细考虑以监测和优化抗菌药物的使用,以减少抗菌素耐药病原体的发生和扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号